fludarabine,cyclophosphamide,allo-316,allo-647
allogene therapeutics
['renal,(-adrenal)', 'allo-316', '$allo', 'allogene therap']
$allo [15s. delayed]: issued press release on april 17, 10:15:00: allogene therapeutics presents interim phase 1 data on allo-316 in renal cell carcinoma at the american association of cancer research (aacr) annual meeting 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time